Course: Association Between Antipsychotic Use and COVID-19 Mortality Among People With Serious Mental Illness
CME Credits: 1.00
Released: 2021-09-22
Schizophrenia spectrum disorders are associated with increased mortality in the setting of COVID-19 infection.- Among several possible explanations for this increased risk is the role of adverse effects of antipsychotic medication, which has not been systematically examined in this population. Our goal was to investigate whether antecedent antipsychotic use was associated with mortality among patients with serious mental illness diagnosed with COVID-19.
Educational Objective
To identify the key insights or developments described in this article
View Full Course